Literature DB >> 23240552

Which factors influence quality of life in acne patients?

S Zauli1, S Caracciolo, A Borghi, M Ricci, S Giari, A Virgili, V Bettoli.   

Abstract

BACKGROUND: The factors that impact quality of life in acne patient are not fully understood.
OBJECTIVE: The purpose of this study was to assess the relationship between quality of life with (i) acne severity; (ii) the duration of this cutaneous disease; and (iii) the gender.
METHODS: Leeds scale to quantify acne severity, and Assessment of the Psychological and Social Effects of Acne (APSEA) score to evaluate quality of life were used. An unselected consecutive group of 50 males and 50 females affected by facial acne filled in the APSEA questionnaire during the first visit and after 3 months of treatment.
RESULTS: (i) At the beginning of the treatment, APSEA score correlated with acne severity, but at the end of it, the reduction of APSEA score was less marked than the reduction of acne severity. (ii) Acne duration does not significantly influence APSEA score. (iii) Before treatment, acne severity was comparable between females and males, whereas APSEA score was significantly higher in females than in males.
CONCLUSION: The quality life of acne patients could be influenced by social and emotional factors. The discrepancy of the results reported in literature regarding the correlation of the quality of life with acne severity and duration probably depends on the sensitivity and specificity of the questionnaire used to assess the quality of life. Among the different available scores to measure quality of life in acne patients, in the authors' experience, APSEA score is a valuable one.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2012        PMID: 23240552     DOI: 10.1111/jdv.12053

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Psychosocial Impact of Postinflammatory Hyperpigmentation in Patients with Acne Vulgaris.

Authors:  Kavita Darji; Reena Varade; Daniel West; Eric S Armbrecht; Mary A Guo
Journal:  J Clin Aesthet Dermatol       Date:  2017-05-01

2.  Quality of Life of Cohabitants of People Living with Acne.

Authors:  Eliseo Martínez-García; Salvador Arias-Santiago; Enrique Herrera-Acosta; Andrew Affleck; Enrique Herrera-Ceballos; Agustin Buendía-Eisman
Journal:  Acta Derm Venereol       Date:  2020-10-14       Impact factor: 3.875

3.  Acne-Related Quality of Life Among Female Adults of Different Races/Ethnicities.

Authors:  Joe Gorelick; Selena R Daniels; Ariane K Kawata; Arnold Degboe; Teresa K Wilcox; Caroline T Burk; Tracee Douse-Dean
Journal:  J Dermatol Nurses Assoc       Date:  2015-05

4.  Association of brain-derived neurotrophic factor levels and depressive symptoms in young adults with acne vulgaris.

Authors:  Hong-Yi He; Jin-Lan Tian; Yong-Qiong Deng; Xia Xiong; Yang Xu; Yong-Mei Liao; Jing Fang; Xia Feng; Xin Ye; Chang-Qiang Li
Journal:  BMC Psychiatry       Date:  2019-06-24       Impact factor: 3.630

5.  Quality of life in Montenegrin pupils with acne.

Authors:  Milena Ražnatović Đurović; Milica Đurović; Janko Janković; Slavenka Janković
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

6.  The association between acne care provision and quality of life: A cross-sectional survey.

Authors:  Femke de Vries; Rieke Driessen; Esther Tjin; Anissa Westenberg; Hans Vehof; Peter van de Kerkhof
Journal:  Health Sci Rep       Date:  2022-02-08

7.  Pilot study for the evaluation and adaptation of a Four Item-Acne-Scar Risk Assessment Tool (4-ASRAT): a resource to estimate the risk of acne-induced scars.

Authors:  Jorge Estrella Porter; Mikaela Camacho; María Isabel Viteri; Katherine Aguilar; Drifa Belhadi; Vincenzo Bettoli; Anita Del Rocío Buestán; Brigitte Dréno; Pablo Endara; Alison Layton; Nelly Machado; Rosa Mateus; Jerry Tan; Enrique Terán; Paola Yépez; Jonathan Guillemot
Journal:  F1000Res       Date:  2020-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.